El mercado de diagnóstico SIBO fue valorado en 138.324,23 mil dólares en 2020, y se prevé que alcance los 194.604,51 mil dólares en 2028; se espera que crezca a una tasa compuesta anual del 4,4 % entre 2021 y 2028.
El crecimiento excesivo de bacterias del intestino delgado (SIBO) se observa comúnmente en presencia de uno o más factores predisponentes. condiciones. Varía mucho según los trastornos subyacentes y las características de la microbiota de los pacientes y los organismos. SIBO produce síntomas gastrointestinales similares al SII, que podrían ser asintomáticos. En el peor de los casos, puede provocar un verdadero síndrome de malabsorción. La presencia de SIBO generalmente se diagnostica con pruebas de hidrógeno lactulosa y glucosa en el aliento. Estas pruebas se realizan ampliamente en todos los entornos clínicos debido a sus bajos costos, no invasivos, suficiente precisión y reproducibilidad.
El mercado de diagnóstico SIBO está segmentado según de diagnóstico, tipo y geografía. Según la geografía, el mercado está segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y América del Sur y Central. El informe ofrece información y un análisis en profundidad del mercado de diagnóstico SIBO haciendo hincapié en varios parámetros, como las tendencias del mercado, los avances tecnológicos, la dinámica del mercado y el análisis del panorama competitivo de los principales actores del mercado en todo el mundo. También incluye análisis de impacto de COVID-19 en todas las regiones. Se estima que es probable que el mercado tenga una tasa de crecimiento más lenta durante el período previsto debido a los servicios de salud restringidos y la situación de bloqueo causada por la pandemia de COVID-19.
Regiones lucrativas para el mercado de diagnóstico SIBOPerspectivas del mercado
Prevalencia creciente de irritabilidad Síndrome intestinal (SII) y SIBO
El síndrome del intestino irritable (SII) es el trastorno gastrointestinal comúnmente diagnosticado con dolor abdominal y hábitos intestinales alterados que resultan con síntomas asociados como hinchazón, malabsorción y síntomas sistémicos. La incidencia del SII está aumentando a un ritmo significativo en todo el mundo. Según un artículo de investigación, 'Prevalencia y carga mundial de los trastornos gastrointestinales funcionales, resultados del estudio global de la Fundación Roma'. publicado por Elsevier Inc. en 2021, la mayoría de los países tienen una tasa de prevalencia del 2 al 6%. Países como Japón, China, Rusia, Sudáfrica y Estados Unidos tienen una tasa de prevalencia del 2,2%, 2,3%, 5,9%, 5,9% y 5,3%, respectivamente. La creciente prevalencia del SII en todo el mundo se debe a los cambios en el estilo de vida y los hábitos alimentarios. El crecimiento excesivo de bacterias en el intestino delgado (SIBO) está ampliamente asociado con el SII.
Del mismo modo, SIBO muestra síntomas similares a los del SII. Los avances tecnológicos ahora han permitido el diagnóstico de SIBO al mismo tiempo que se diagnostica el SII. Por lo tanto, la prevalencia de SIBO se comprende e informa ampliamente en todo el mundo. Por ejemplo, según un artículo, "Sobrecrecimiento bacteriano del intestino delgado: una revisión basada en casos" publicado en el Journal of Patient-Centered Research and Reviews (JPCRR) en noviembre de 2015, entre el 30 y el 85 % de los pacientes adultos con SII tienen probabilidades de desarrollar SIBO. De manera similar, según los datos recientes publicados en 2020 por el Colegio Americano de Gastroenterología, ~78 % de los pacientes con SII viven con SBIO; por tanto, es una condición predominantemente evaluada. Por lo tanto, se estima que la prevalencia del SII y el SIBO crecerá significativamente en el futuro cercano, lo que conducirá a un diagnóstico cada vez mayor y al eventual crecimiento del mercado.
Información basada en diagnóstico
Basada En cuanto al diagnóstico, el mercado de diagnóstico SIBO se segmenta en pruebas de aliento, aspiración de intestino delgado y prueba de cultivo de líquidos, análisis de sangre y otros. En 2020, el segmento de pruebas de aliento tuvo la mayor participación del mercado y también se espera que crezca al ritmo más rápido en los próximos años. El crecimiento se atribuye a sus ventajas, como el mercado global de diagnóstico SIBO, no invasivo, fácil de usar, simple y de bajo costo.
, por diagnóstico: 2020 y 2020 2028Información basada en tipos
Según el tipo, el mercado de diagnóstico SIBO se segmenta en SIBO con predominio de hidrógeno y predominio de metano SIBO y SIBO recurrente. En 2020, el segmento SIBO, predominantemente de hidrógeno, tuvo la mayor participación del mercado y se espera que el mismo segmento crezca al ritmo más rápido durante los próximos años.
Información estratégica
Las estrategias orgánicas, como el lanzamiento de productos, son comúnmente adoptadas por los actores del mercado para satisfacer la demanda cambiante de los clientes y mantener sus servicios mejorados. Por ejemplo, en febrero de 2020, Commonwealth Diagnostics International (CDI), Inc., anunció el relanzamiento comercial de IBSchek, el primer análisis de sangre con biomarcadores clínicamente validado para el síndrome del intestino irritable con diarrea predominante y de tipo mixto (SII-D, SII -M) en un nuevo kit de recolección capilar casero.
Por diagnóstico
- Prueba de aliento
- 14C Prueba de aliento con xilosa
- Pruebas de aliento de hidrógeno
- Prueba de aliento de ácido glicocólico 14C
- Pruebas de malabsorción
- Pequeño Prueba de aspirado intestinal y cultivo de líquido
- Prueba de sangre
- Otros
Por tipo
- SIBO con predominio de hidrógeno
- SIBO con predominio de metano
- SIBO recurrente
Por geografía
- América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania< /li>
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de APAC
- Oriente Medio y Asia. África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de MEA
- América del Sur y Central (SCAM)
- Brasil
- Argentina
- Resto de SCAM
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Bienestar vibrante
- Grupo médico de Health Associates
Perfiles de la empresa
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Small intestinal bacterial growth (SIBO) is commonly seen in the presence of one or more predisposing conditions. It varies highly based on the underlying disorders and microbiota characteristics of patients and organisms. SIBO results in gastrointestinal IBS-like symptoms, which could be asymptomatic. In worse cases, it may result in real malabsorption syndrome. The presence of SIBO is generally diagnosed with hydrogen lactulose and glucose breath tests. These tests are widely performed in every clinical setting due to their low costs, non-invasively, sufficient accuracy, and reproducibility.
Key factors that are driving growth of the market are increasing incidence of IBS and SIBO and advantages offered by breath tests. However, limitation of diagnostics is a key factor restraining the market growth.
The cost is based on the type of diagnostics test. For instance, the hydrogen breath test is much cheaper than any other test. The cost of the test ranges from US$ 145–US$ 400. Likewise, the cost of endoscopy is ~US$ 135.
The List of Companies - Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
- Genova Diagnostics
- SIBO Diagnostics
- Commonwealth Diagnostics International
- Aerodiagnostics, LLC
- SIBOTest
- Metabolic Solutions, Inc.
- Pivotal Diagnostics
- DirectLabs, LLC
- Vibrant Wellness
- Health Associates Medical Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)